Free CME from PeerView


Neurology CME

Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Moving Toward the Future in MS Management: What's the Latest on BTK Inhibition?
Jiwon Oh, MD, PhD, FRCPC
November 15, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
The Future Looks Bright for People With Fabry Disease: Improving Diagnosis and Expanding Treatment Options
David G. Warnock, MD
November 15, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Managing Disorders of Hypersomnolence: Reducing Patient Burdens, Protecting Patient Health
Richard K. Bogan, MD, FCCP, FAASM
November 04, 2022
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors
Erik P. Sulman, MD, PhD
October 24, 2022
Credits: 1.0 CME / NCPD / CPE
University of Florida College of Medicine
A Targeted Approach to Management of Generalized Myasthenia Gravis: The Latest on Novel Therapies That Improve Patient Outcomes
James F. Howard Jr., MD
October 02, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Encouraging News in Rett Syndrome: Steps Towards a Timely, Accurate Diagnosis and Treatment Breakthroughs
Jeffrey L. Neul, MD, PhD
September 14, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Optimizing Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy: Honing Diagnostic Accuracy, Personalizing Treatment Plans
David Cornblath, MD
July 21, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Therapeutic Advances in the Early Treatment of Alzheimer’s Disease: Expert Insights on Novel Biomarkers and Emerging Disease-Modifying Therapies
David Weidman, MD
June 20, 2022
Credits: 1.0 CME / NCPD / CPE
PVI, PeerView Institute for Medical Education
Re-Examining S1PR Modulation From All Angles in Relapsing Multiple Sclerosis: Impact on Physical and Cognitive Outcomes, and Practical Considerations of Long-Term Therapy
Bruce Cree, MD, PhD, MAS
June 03, 2022
Credits: 1.0 CME / NCPD / CPE
PVI, PeerView Institute for Medical Education
Innovations and Imaging in Multiple Sclerosis: Examining the Evidence, Looking Toward the Future of Bruton Tyrosine Kinase Inhibitors
Benjamin M. Greenberg, MD, MHS / Professor Anthony Traboulsee, MD
June 02, 2022
Credits: 0.5 CME
University of Florida College of Medicine
Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care
Bruce Cree, MD, PhD, MAS
May 25, 2022
Credits: 1.0 CME / CPE
PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
Joe R. Anderson, PharmD, PhC
May 06, 2022
Credits: 2.0 CME / MOC
Purdue University
Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
Liana G. Apostolova, MS, MD, FAAN
March 18, 2022
Credits: 0.5 CME / NCPD
Medical Learning Institute, Inc.
Breakthroughs in Spinal Muscular Atrophy: Managing the Life-Changing Impact of Gene Replacement Therapy
Julie Parsons, MD
March 01, 2022
Credits: 0.5 CME
Penn State College of Medicine
Leveraging S1PR Modulators to Provide Patient-Centered MS Care: An Expert-Driven Review of the Data
Mark S. Freedman, MD
February 28, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
Amit Bar-Or, MD, FRCPC / Daniel S. Reich, MD, PhD
February 26, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
The Expanding Role of Neuroimaging in Alzheimer’s Disease Diagnosis and Management: Is Radiology Prepared for New Challenges?
Tammie L.S. Benzinger, MD, PhD
February 15, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
Gregory W. Albers, MD / S. Claiborne “Clay” Johnston, MD, PhD
February 11, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder
Anita H. Clayton, MD
December 31, 2021
Bradley S. Miller, MD, PhD
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
Bradley S. Miller, MD, PhD
December 30, 2021
Credits: 1.0 CME
Medical Learning Institute, Inc.
Overcoming Challenges in the Recognition and Management of Adult ADHD in Primary Care: Optimizing Outcomes to Reduce Disease Burden and Improve Quality of Life
Lenard A. Adler, MD / Oren Mason, MD
December 23, 2021
Medical Learning Institute, Inc.
A New Wave of Progress in Glioblastoma: Expert Guidance on Delivering Modern Personalized Care With Tumor Treating Fields and Novel Systemic Approaches
Manmeet Ahluwalia, MD, MBA
November 20, 2021
Medical Learning Institute, Inc.
Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
Benjamin M. Greenberg, MD, MHS
October 28, 2021
Medical Learning Institute, Inc.
Exploring the Convergence of Advances in S1P Receptor Modulation With Progress in Understanding Brain Atrophy and Cognition Measures in Multiple Sclerosis
Bruce Cree, MD, PhD, MAS
October 26, 2021
Medical Learning Institute, Inc.
On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
Professor Dame Pamela J. Shaw
October 22, 2021
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
Bruce R. Korf, MD, PhD / Nicole J. Ullrich, MD, PhD, MMSci
July 15, 2021
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
R. Robert Auger, MD, FAASM, FAPA, DABPN
June 25, 2021
Medical Learning Institute, Inc.
Managing Motor Complications in Parkinson’s Disease: Evaluating the Role of On-Demand Therapies for “Off” Episodes
Stuart H. Isaacson, MD
June 22, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView